Safety and Feasibility of Intravenous Paracetamol for Patent Ductus Arteriosus in Indomethacin-/Ibuprofen-Resistant or -Contraindicated Preterm Infants: A Case Series

Safety and Feasibility of Intravenous Paracetamol for Patent Ductus Arteriosus in Indomethacin-/Ibuprofen-Resistant or -Contraindicated Preterm Infants: A Case Series

Background Although indomethacin and ibuprofen are the standard treatments for hemodynamically significant patent ductus arteriosus (hsPDA), they are associated with renal impairment and gastrointestinal complications. Paracetamol for hsPDA closure does not provoke a peripheral vasoconstrictive effe...

Full description

Bibliographic Details
Main Authors: Ayumi Oshima, Shun Matsumura, Ayaka Iwatani, Machiko Morita, Sumie Fujinuma, Yukiko Motojima, Kosuke Tanaka, Satoshi Masutani, Kazuhiko Kabe, Keiko Ueda, Fumihiko Namba
Format: Article
Language:English
Published: Thieme Medical Publishers, Inc. 2020-01-01
Series:American Journal of Perinatology Reports
Subjects:
ibuprofen
indomethacin
paracetamol
patent ductus arteriosus
premature infant
surgical closure
Online Access:http://www.thieme-connect.de/DOI/DOI?10.1055/s-0040-1702945

Internet

http://www.thieme-connect.de/DOI/DOI?10.1055/s-0040-1702945

Similar Items